| Product Code: ETC13258201 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Haemophilia Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Haemophilia Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Haemophilia Market Revenues & Volume, 2021 & 2031F |
3.3 North America Haemophilia Market - Industry Life Cycle |
3.4 North America Haemophilia Market - Porter's Five Forces |
3.5 North America Haemophilia Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Haemophilia Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 North America Haemophilia Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 North America Haemophilia Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.9 North America Haemophilia Market Revenues & Volume Share, By Patient, 2021 & 2031F |
3.10 North America Haemophilia Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.11 North America Haemophilia Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.12 North America Haemophilia Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 North America Haemophilia Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Haemophilia Market Trends |
6 North America Haemophilia Market, 2021 - 2031 |
6.1 North America Haemophilia Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Haemophilia Market, Revenues & Volume, By Medication, 2021 - 2031 |
6.1.3 North America Haemophilia Market, Revenues & Volume, By Desmopressin, 2021 - 2031 |
6.1.4 North America Haemophilia Market, Revenues & Volume, By Emicizumab, 2021 - 2031 |
6.1.5 North America Haemophilia Market, Revenues & Volume, By Anti-fibrinolytics, 2021 - 2031 |
6.1.6 North America Haemophilia Market, Revenues & Volume, By ITI Therapy, 2021 - 2031 |
6.1.7 North America Haemophilia Market, Revenues & Volume, By Gene Therapy, 2021 - 2031 |
6.1.8 North America Haemophilia Market, Revenues & Volume, By Fibrin Sealants, 2021 - 2031 |
6.1.9 North America Haemophilia Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 North America Haemophilia Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Haemophilia Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.2.3 North America Haemophilia Market, Revenues & Volume, By Injectable, 2021 - 2031 |
6.2.4 North America Haemophilia Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 North America Haemophilia Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Haemophilia Market, Revenues & Volume, By Blood Test, 2021 - 2031 |
6.3.3 North America Haemophilia Market, Revenues & Volume, By Genetic Tests, 2021 - 2031 |
6.3.4 North America Haemophilia Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 North America Haemophilia Market, Revenues & Volume, By Patient, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 North America Haemophilia Market, Revenues & Volume, By Pediatric, 2021 - 2031 |
6.4.3 North America Haemophilia Market, Revenues & Volume, By Adult, 2021 - 2031 |
6.5 North America Haemophilia Market, Revenues & Volume, By Type, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Haemophilia Market, Revenues & Volume, By Haemophilia A, 2021 - 2031 |
6.5.3 North America Haemophilia Market, Revenues & Volume, By Haemophilia B, 2021 - 2031 |
6.5.4 North America Haemophilia Market, Revenues & Volume, By Haemophilia C, 2021 - 2031 |
6.5.5 North America Haemophilia Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 North America Haemophilia Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 North America Haemophilia Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.6.3 North America Haemophilia Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.6.4 North America Haemophilia Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.6.5 North America Haemophilia Market, Revenues & Volume, By Others, 2021 - 2031 |
6.7 North America Haemophilia Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 North America Haemophilia Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.7.3 North America Haemophilia Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
6.7.4 North America Haemophilia Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
6.7.5 North America Haemophilia Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Haemophilia Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Haemophilia Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.2.1 United States (US) Haemophilia Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.2.2 Canada Haemophilia Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.2.3 Rest of North America Haemophilia Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.3 North America Haemophilia Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
7.3.1 United States (US) Haemophilia Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.3.2 Canada Haemophilia Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.3.3 Rest of North America Haemophilia Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4 North America Haemophilia Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
7.4.1 United States (US) Haemophilia Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
7.4.2 Canada Haemophilia Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
7.4.3 Rest of North America Haemophilia Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
7.5 North America Haemophilia Market, Revenues & Volume, By Patient, 2021 - 2031 |
7.5.1 United States (US) Haemophilia Market, Revenues & Volume, By Patient, 2021 - 2031 |
7.5.2 Canada Haemophilia Market, Revenues & Volume, By Patient, 2021 - 2031 |
7.5.3 Rest of North America Haemophilia Market, Revenues & Volume, By Patient, 2021 - 2031 |
7.6 North America Haemophilia Market, Revenues & Volume, By Type, 2021 - 2031 |
7.6.1 United States (US) Haemophilia Market, Revenues & Volume, By Type, 2021 - 2031 |
7.6.2 Canada Haemophilia Market, Revenues & Volume, By Type, 2021 - 2031 |
7.6.3 Rest of North America Haemophilia Market, Revenues & Volume, By Type, 2021 - 2031 |
7.7 North America Haemophilia Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.7.1 United States (US) Haemophilia Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.7.2 Canada Haemophilia Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.7.3 Rest of North America Haemophilia Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.8 North America Haemophilia Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.8.1 United States (US) Haemophilia Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.8.2 Canada Haemophilia Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.8.3 Rest of North America Haemophilia Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 North America Haemophilia Market Key Performance Indicators |
9 North America Haemophilia Market - Export/Import By Countries Assessment |
10 North America Haemophilia Market - Opportunity Assessment |
10.1 North America Haemophilia Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Haemophilia Market Opportunity Assessment, By Treatment, 2021 & 2031F |
10.3 North America Haemophilia Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.4 North America Haemophilia Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
10.5 North America Haemophilia Market Opportunity Assessment, By Patient, 2021 & 2031F |
10.6 North America Haemophilia Market Opportunity Assessment, By Type, 2021 & 2031F |
10.7 North America Haemophilia Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10.8 North America Haemophilia Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
11 North America Haemophilia Market - Competitive Landscape |
11.1 North America Haemophilia Market Revenue Share, By Companies, 2022 |
11.2 North America Haemophilia Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here